Skip to main content
SpringerLink
Log in

Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The effect of the selective 5-HT3 receptor antagonists, ondansetron and MDL 72222, against various behaviours elicited by naloxone-precipitated morphine withdrawal were examined. Rats made dependent upon morphine by the subcutaneous implantation of a 75 mg pellet, when challenged with naloxone (0.5 mg/kg SC), 3 or 4 days later exhibited a wide range of behaviours including wet dog shakes, paw shakes, salivation and a marked weight loss. Pre-treatment with ondansetron (0.01–1 mg/kg SC) or MDL 72222 (1–3 mg/kg SC) failed to affect the incidence of these responses except weight loss, which was attenuated by both treatments. At doses similar to and below those required to elicit the withdrawal syndrome, naloxone produced a single-trial place aversion in morphine dependent rats. The place aversion produced by naloxone (0.05 mg/kg SC) was antagonized by pre-treatment of ondansetron (0.1–1 mg/kg SC) and MDL 72222 (1 mg/kg SC) prior to conditioning. Chlordiazepoxide (10 mg/kg IP) but not gepirone (3–10 mg/kg SC) was similarly effective. It is concluded that 5-HT3 antagonists may attenuate some but not all behavioural signs associated with morphine withdrawal. Reasons for this apparent selectivity are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Barnes JM, Barnes NM, Champaneria S, Costall B, Naylor RJ (1990a) Characterization and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(s)-zacopride in the forebrain of the rat. Neuropharmacology 29:1037–1046

    Google Scholar 

  • Barnes JM, Barnes NM, Costall B, Naylor IL, Naylor RJ, Rudd JA (1990b) Topographical distribution of 5-HT3 receptor recognition sites in the ferret brain stem. Naunyn-Schmiedebergs Arch Pharmacol 342:17–21

    Google Scholar 

  • Barnes JM, Costall B, Coughlan J, Domeney AM, Gerrard PA, Kelly ME, Naylor RJ, Onaivi ES, Tomkins DM, Tyers MB (1990c) The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates. Pharmacol Biochem Behav 35:955–962

    Google Scholar 

  • Blasig J, Reinhold K, Zieglgansberger S (1973) Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacology 33:19–38

    Google Scholar 

  • Childress AR, McLellan AT, Ehrman R, O'Brien CP (1988) Classically conditioned responses in opioid and cocaine dependence: a role in relapse? NIDA Res Mongr 84:25–43

    Google Scholar 

  • Chopin P, Briley M (1987) Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission. TIPS 8:383–388

    Google Scholar 

  • Cicero TJ, Meyer ER (1973) Morphine pellet implantation in rats: quantitative assessment of tolerance and dependence. J Pharmacol Exp Ther 184:404–408

    Google Scholar 

  • Costall B, Domeney AM, Naylor RJ, Tyers MB (1987) Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of rat and marmoset brain. Br J Pharmacol 92:881–894

    Google Scholar 

  • Costall B, Jones BJ, Kelly ME, Naylor RJ, Oakley NR, Onaivi ES, Tyers MB (1989a) The effect of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam. Pharmacol Biochem Behav 34:769–778

    Google Scholar 

  • Costall B, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB (1989b) Neuroanatomical sites of action of 5-HT3 receptor agonists and antagonists for alteration of aversive behaviour in the mouse. Br J Pharmacol 96:325–332

    Google Scholar 

  • Costall B, Jones BJ, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB (1990a) Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse. Pharmacol Biochem Behav 36:339–344

    Google Scholar 

  • Costall B, Jones BJ, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB (1990b) Sites of action of ondansetron to inhibit withdrawal from drugs of abuse. Pharmacol Biochem Behav 36:97–104

    Google Scholar 

  • Csanalosi I, Schweizer E, Chase WG, Rickels K (1987) Gepirone in anxiety: a pilot study. J Clin Psychopharmacol 7:31–33

    Google Scholar 

  • Emmett-Oglesby MW, Mathis DA, Moon RTY, Lal H (1990) Animal models of drug withdrawal symptoms. Psychopharmacology 101:292–309

    Google Scholar 

  • Gintzler AR (1979) Serotonin participation in gut withdrawal from opiates. J Pharmacol Exp Ther 211:7–12

    Google Scholar 

  • Goudie AJ, Leathley MJ (1990) Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats. Eur J Pharmacol 185:170–186

    Google Scholar 

  • Hand TH, Koob GF, Stinus L, Le Moal M (1988) Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats. Brain Res 474:363–368

    Google Scholar 

  • Higgins GA, Jones BJ, Oakley NR, Tyers MB (1989a) Evidence that the amygdala and not the area postrema is involved in the putative anxiolytic effects of 5-HT3 receptor antagonists. Br J Pharmacol 98:635P

  • Higgins GA, Kilpatrick GJ, Bunce KT, Jones BJ, Tyers MB (1989b) 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br J Pharmacol 97:247–255

    Google Scholar 

  • Higgins GA, Jones BJ, Oakley NR, Tyers MB (1991) Evidence that the amygdala is involved in the disinhibitory effect of 5-HT3 receptor antagonists. Psychopharmacology (in press)

  • Johnson SM, Westfall DP, Howard SA, Fleming WW (1978) Sensitivities of the isolated ileal longitudinal smooth muscle-myenteric plexus and hypogastric nerve-vas deferens of the guinea pig after chronic morphine pellet implantation. J Pharmacol Exp Ther 204:54–66

    Google Scholar 

  • Jones BJ, Costall B, Domeney AM, Kelly ME, Naylor RJ, Oakley NR, Tyers MB (1988) The potential anxiolytic activity of GR38032F, a 5-HT3 receptor antagonist. Br J Pharmacol 93:985–993

    Google Scholar 

  • Kehne JH, Cassella JV, Davis M (1988) Anxiolytic effects of buspirone and gepirone in the fear potentiated startle paradigm. Psychopharmacology 94:8–13

    Google Scholar 

  • Kilpatrick GJ, Jones BJ, Tyers MB (1989) Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species. Eur J Pharmacol 159:157–164

    Google Scholar 

  • Koenig JL, Meltzer HY, Gudelsky GA (1988) 5-Hydroxytryptamine1A receptor mediated effects of buspirone, gepirone and ipsapirone. Pharmacol Biochem Behav 29:711–715

    Google Scholar 

  • Laschka E, Teschemacher H, Mehraein P, Herz A (1976) Sites of action of morphine involved in the development of physical dependence in rats. Psychopharmacology 46:141–147

    Google Scholar 

  • Lecrubier Y (1991) 5-HT3 receptors in anxiety disorders. J Psychopharmacol (in press)

  • Liebundgut U, Lancranjan I (1987) First results with ICS 205–930 (5-HT3 antagonist) in prevention of chemotherapy-induced emesis. Lancet i:1198

  • Manning FJ, Jackson MC Jr. (1977) Enduring effects of morphine pellets revealed by conditioned taste aversion. Psychopharmacology 51:279–283

    Google Scholar 

  • Miner WD, Sanger GJ (1986) Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br J Pharmacol 88:497–499

    Google Scholar 

  • Mucha RF (1987) Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat. Brain Res 418:214–220

    Google Scholar 

  • Mucha RF, Iversen SD (1984) Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination. Psychopharmacology 82:241–247

    Google Scholar 

  • Mucha RF, Van der Kooy D, O'Shaughnessy M, Bucenieks P (1982) Drug reinforcement studied by the use of place conditioning in rat. Brain Res 243:91–105

    Google Scholar 

  • Mucha RF, Gritti MD, Kim C (1986) Aversive properties of opiate withdrawal studied in rats. NIDA Res Monogr 75:567–570

    Google Scholar 

  • Oakley NR, Jones, BJ, Tyers MB, Costall B, Domeney AM (1988) The effect of GR38032F on alcohol consumption in the marmoset. Br J Pharmacol 95:870P

    Google Scholar 

  • Pinkus LM, Sarbin NS, Barefoot DS, Gordon JC (1989) Association of [3H]zacopride with 5-HT3 binding sites. Eur J Pharmacol 168:355–362

    Google Scholar 

  • Pratt GD, Bowery NG, Kilpatrick GJ, Leslie RA, Barnes NM, Naylor RJ, Jones BJ, Nelson DR, Palacios JM, Slater P, Reynolds DJM (1990) Concensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain. TIPS 11:135–137

    Google Scholar 

  • Preston GC, Broks P, Traub M, Ward C, Poppleton P, Stahl SM (1988) Effects of lorazepam on memory, attention and sedation in man. Psychopharmacology 95:208–215

    Google Scholar 

  • Richardson BP, Engel G (1986) The pharmacology and function of 5-HT3 receptors. TINS 9:424–428

    Google Scholar 

  • Roy-Byrne PP, Uhde TW, Holcomb H, Thomspon K, King AK, Weingartner H (1987) Effects of diazepam on cognitive process in normal subjects. Psychopharmacology 91:30–33

    Google Scholar 

  • Schultz R, Goldstein A (1973) Morphine tolerance and supersensitivity to 5-hydroxytryptamine in the myenteric plexus of the guinea-pig. Nature 244:168–170

    Google Scholar 

  • Sellers EM (1978) Clinical pharmacology and therapeutics of benzodiazepines. Can Med Assoc J 118:1533–1538

    Google Scholar 

  • Sharpe LG, Jaffe JH (1989) Captopril and capsaicin modify opioid withdrawal in the morphine-dependent rat. Pharmacol Biochem Behav 33:899–902

    Google Scholar 

  • Siegel S (1988) Drug anticipation and the treatment of dependence. NIDA Res Mongr 84:1–24

    Google Scholar 

  • Stinus L, Le Moal M, Koob GF (1990) Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37:767–773

    Google Scholar 

  • Waeber C, Pinkus LM, Palacios JM (1990) The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain. Eur J Pharmacol 181:283–287

    Google Scholar 

  • Wei E, Loh HH, Way EL (1973) Quantitative aspects of precipitated abstinence in morphine-dependent rats. J Pharmacol Exp Ther 184:398–403

    Google Scholar 

  • Wise RA (1988) The neurobiology of craving: implication for the understanding and treatment of addiction. J Abnorm Psychol 97:118–132

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Psychopharmacology Program, Addiction Research Foundation and Departments of Pharmacology and Medicine, University of Toronto, 33 Russell Street, M5S 2S1, Toronto, Canada

    Guy A. Higgins, Peter Nguyen, Narges Joharchi & Edward M. Sellers

Authors
  1. Guy A. Higgins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Narges Joharchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Edward M. Sellers
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The views expressed in this manuscript are those of the authors and do not necessarily reflect those of the Addiction Research Foundation.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Higgins, G.A., Nguyen, P., Joharchi, N. et al. Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal. Psychopharmacology 105, 322–328 (1991). https://doi.org/10.1007/BF02244425

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02244425

Key words

Search

Navigation